TCR2 THERAPEUTICS INC. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tcr2 Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q1 2023.
  • Tcr2 Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending March 31, 2023 was 39.2M shares, a 1.81% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 39.2M +698K +1.81% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 39.2M +707K +1.84% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 38.7M +437K +1.14% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 38.6M +418K +1.09% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 38.5M +387K +1.02% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 38.5M +4.98M +14.9% Dec 31, 2021 10-K 2023-03-23
Q3 2021 38.2M +4.84M +14.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 38.2M +14.1M +58.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 38.2M +14.1M +58.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 33.5M +9.54M +39.8% Dec 31, 2020 10-K 2022-03-22
Q3 2020 33.4M +9.44M +39.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 24.1M +248K +1.04% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 24.1M +264K +1.11% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 24M +23.3M +3199% Dec 31, 2019 10-K 2021-03-16
Q3 2019 23.9M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 23.9M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 23.8M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 727K Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.